Byssinosis pathophysiology: Difference between revisions
No edit summary |
mNo edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | {{CMG}} | ||
{{Byssinosis}} | {{Byssinosis}} | ||
==Overview== | ==Overview== | ||
==Pathophysiology== | ==Pathophysiology== | ||
===Pathologic Findings=== | ===Pathologic Findings=== | ||
====Acute HP==== | ====Acute HP==== | ||
There are noncaseating interstitial granulomas and mononuclear cell infiltration in a peribronchial distribution. Giant | There are noncaseating interstitial [[granulomas]] and [[mononuclear cell]] infiltration in a peribronchial distribution. [[Giant cell]]s are prominent. | ||
====Subacute or intermittent HP==== | ====Subacute or intermittent HP==== | ||
The noncaseating granulomas are more well formed. There is bronchiolitis with or without organizing pneumonia. Interstitial fibrosis is present. | The noncaseating granulomas are more well formed. There is [[bronchiolitis]] with or without organizing [[pneumonia]]. Interstitial [[fibrosis]] is present. | ||
====Chronic HP==== | ====Chronic HP==== | ||
There is chronic interstitial inflammation and alveolar destruction (honeycombing). There is dense fibrosis. The pathologic findings of chronic HP that are often associated with a poorer prognosis include the following 3 patterns of fibrosis: | There is chronic interstitial inflammation and [[alveolar]] destruction (honeycombing). There is dense fibrosis. The pathologic findings of chronic HP that are often associated with a poorer prognosis include the following 3 patterns of fibrosis: | ||
* '''Predominantly peripheral fibrosis:''' in a patchy pattern with architectural distortion and fibroblast foci similar to usual interstitial pneumonia (UIP) | * '''Predominantly peripheral fibrosis:''' in a patchy pattern with architectural distortion and fibroblast foci similar to usual interstitial pneumonia (UIP) | ||
| Line 21: | Line 23: | ||
===Pathophysiology of Immune Response=== | ===Pathophysiology of Immune Response=== | ||
Exposure results in the development of circulating immunoglobulin G antibodies that are specific for the offending antigen. This antibody that forms is called the precipitating antibody, and it reacts with the specific putative antigen to form a precipitant. Initially the disease process was thought to be immunecomplex-mediated. However, subsequent studies have demonstrated that cell-mediated immunity is more important. | Exposure results in the development of circulating [[immunoglobulin G]] antibodies that are specific for the offending antigen. This antibody that forms is called the precipitating antibody, and it reacts with the specific putative antigen to form a precipitant. Initially the disease process was thought to be immunecomplex-mediated. However, subsequent studies have demonstrated that cell-mediated immunity is more important. | ||
In the acute phase, there is a local increase in neutrophils in the alveoli and small airways. This is followed by an influx of mononuclear cells which release proteolytic enzymes, prostaglandins, and | In the acute phase, there is a local increase in [[neutrophils]] in the [[alveoli]] and small airways. This is followed by an influx of mononuclear cells which release proteolytic enzymes, [[prostaglandins]], and [[leukotriene]]s. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Pulmonology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 20:51, 7 June 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Byssinosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Byssinosis pathophysiology On the Web |
|
American Roentgen Ray Society Images of Byssinosis pathophysiology |
|
Risk calculators and risk factors for Byssinosis pathophysiology |
Overview
Pathophysiology
Pathologic Findings
Acute HP
There are noncaseating interstitial granulomas and mononuclear cell infiltration in a peribronchial distribution. Giant cells are prominent.
Subacute or intermittent HP
The noncaseating granulomas are more well formed. There is bronchiolitis with or without organizing pneumonia. Interstitial fibrosis is present.
Chronic HP
There is chronic interstitial inflammation and alveolar destruction (honeycombing). There is dense fibrosis. The pathologic findings of chronic HP that are often associated with a poorer prognosis include the following 3 patterns of fibrosis:
- Predominantly peripheral fibrosis: in a patchy pattern with architectural distortion and fibroblast foci similar to usual interstitial pneumonia (UIP)
- Homogeneous linear fibrosis: similar to fibrotic nonspecific interstitial pneumonia (NSIP)
- Irregular predominantly peribronchiolar fibrosis
Pathophysiology of Immune Response
Exposure results in the development of circulating immunoglobulin G antibodies that are specific for the offending antigen. This antibody that forms is called the precipitating antibody, and it reacts with the specific putative antigen to form a precipitant. Initially the disease process was thought to be immunecomplex-mediated. However, subsequent studies have demonstrated that cell-mediated immunity is more important.
In the acute phase, there is a local increase in neutrophils in the alveoli and small airways. This is followed by an influx of mononuclear cells which release proteolytic enzymes, prostaglandins, and leukotrienes.